Keratan sulfate proteoglycan (KSPG) and dermatan sulfate proteoglycan (DSPG) are associated with collagen fibrils in adult rabbit cornea. Because certain cytochemical data suggested that proteoglycans are associated with type VI collagen in the fetal rabbit cornea, we developed polyclonal antibodies specific to the core proteins of rabbit corneal KSPG (lumican and/or fibromodulin) and DSPG (decorin and/or biglycan) and used the antibodies as immunocytochemical probes to determine proteoglycan ultrastructural location.
Introduction
Although the types, relative quantities, and organization of macromolecules in extracellular matrices distinguish one connective tissue from another, all have in common collagenous components embedded in a ground substance containing anionic glycosaminoglycans (GAGs) usually covalently bound to protein, constituting proteoglycans (PGs). PGs are highly acidic macromolecules that possess at least one sulfated GAG chain covalently bound to a peptide core. The two major types of GAGs in corneal stroma are keratan sulfate (KS) and dermatan sulfate (DS). Each GAG is a polymer of a disaccharide, in KS N-acetylglucosamine and galactose and in DS N-acetylgalactosamine and glucuronic or iduronic acid. GAG carbohydrates are sulfated to various degrees. Comeal PGs are part of a family of small PGs with core proteins similar in molecular weight and amino acid composition and sequence (5,18,27) .
The KSPGs contain one to three chains of KS N-linked to the core through a mannose-containing linkage oligosaccharide similar to those in complex glycoproteins, and the core protein of corneal KSPG seems to be related to other glycoproteins (18). On the basis of core protein structure, two types of corneal KSPGs have been described, lumican and fibromodulin (5,34). Although the KSPG core proteins differ and are derived from different gene products (23), all seem to be closely related to the proteins of decorin and biglycan (15J4.37). The DSPG isolated from chick (27) and rabbit (unpublished) comea has been cloned and identified as decorin. It contains one DS side chain and one to three N-linked oligosaccharides. There is no indication that biglycan, composed of a core protein highly homologous to decorin but with two GAG chains, is present in normal comea (3) . The structural relationships and functional properties of these PGs are poorly understood, partly owing to the lack of detailed information about macromolecular and cellular binding sites. Nevertheless, the functions of the PGs seem to be related to their general molecular and polyelectrolyte characteristics, their physicochemical properties, their distribution within the tissue, and the association of both GAG and core protein with other extracellular matrix components. PGs of the corneal stroma are believed to be responsible for maintaining corneal hydration, rigidity and transparency but the mechanisms are still unknown. If proper spacing between the stromal collagen fibrils is necessary for transparency (2), the interfibrillar location of PGs suggests that these macromolecules stabilize the spacing by their interactions with components on and between the collagen fibrils. PGs interact with many molecules through ionic interactions. Although size is an important factor, the strength of GAG interactions with other extracellular matrix proteins is related to GAG charge density and usually lacks specificity. The core protein of decorin binds to collagen (35) and inhibits collagen fibrillogenesis (36) . Decorin, as its name im-plies, "decorates" the outer surface of collagen fibrils in a periodic fashion. The core protein is composed mostly of a repeat of a 24 amino-acid unit characterized by an arrangement of conserved leucine residues (27). These repeats have been implicated as basic protein-binding domains. Decorin binds to collagen at specific sites separated by the 67-nm repeat distance of the fibrils. DSPGs in tendon and sclera have been localized to the "d" bands of collagen fibrils with a periodicity of 62 nm (31, 46) .
In cornea, the story is more complex because at least two types of PGs are present, isoforms of KSPG and decorin. Cytochemical evidence indicates that KSPG and DSPG interact with corneal collagen fibrils at either the periodic collagen banding pattern "a" or "c" or at the band "d" or "e" for KSPG or DSPG, respectively (39). The precise arrangement of the corneal PGs presumably reflects specific intermolecular interactions with collagen.
Type VI collagen is abundant between collagen fibrils as fine, filamentous structures containing beads with a periodicity of 100 nm in corneal stroma (6,28). The interaction between PGs and Type VI collagen is suggested cytochemically (33,44) and immunochemically (3). Cytochemical studies failed to show that PGs in fetal cornea are exclusively associated with collagen fibrils (7). Because decorin can bind to Type VI collagen with high affinity (4) and the ultrastructural location of Type VI collagen and PGs in cornea is interfibrillar, we hypothesized that Type VI collagen is associated with corneal PGs in developing rabbit.
In this immunocytochemical study we have used monoclonal antibodies (MAb) to GAGS and Type VI collagen and prepared polyclonal antibodies to the core proteins of corneal PGs to examine the association of KSPG (lumican and/or fibromodulin), DSPG (decorin andlor biglycan), and Type VI collagen in developing rabbit cornea.
Materials and Methods
PG Preparation. Purified KSPG core protein (KSPG/CP) and DSPG core protein (DSPG/CP) from rabbit cornea were gifts of Drs. John D.
Gregory and Shridhar P. Damle (Rockefeller University, New York). Briefly, KSPGlCP was prepared as follows: KSPG from rabbit cornea was extracted and purified as previously described (20) and then digested with keratan sulfate endo-a-galactosidase (keratanase) (Miles Laboratories; Naperville, IL) to remove the KS GAG (7). The digest was chromatographed on a DE 52 column, and the unabsorbed water and 0.25 M NaCl protein-containing fractions were pooled. Subsequent elution with 2 M NaCl removed the oligosaccharides. The pooled protein fractions were then dialyzed and the retentate chromatographed on a BioGel PI00 column under dissociative conditions. After removal of guanidine hydrochloride (GuHCI) with a Biogel P2 column, protein-and hexosamine-containing fractions were digested further with N-glycosidase F (N-Glycanase) (Genzyme; Boston, MA) (7) followed by chromatography on a G 200 column under dissociative conditions. Analysis of the KSPGlCP fraction failed to show hexosamines. KSPGKP, electrophoresed on 16% SDS-PAGE, showed only one band at -40 m (not shown).
Rabbit corneal DSPG was prepared as previously described (20). The DSPG-containing fraction from the ion exchange column was put on a Sepharose CL4B column in 4 M GuHCl and the galactosamine-containing zone treated with Keratanase. The enzymatic digest was separated from DSPG on a Sepharose CL6B column containing 4 M GuHCI, followed by DEAE-cellulose, eluted with 3 M NaCI. The DSPG was then digested with chondroitinase ABC (Miles) (7) and the core isolated on a BioGel PlOO column in 0.2 M acetate. The DSPGXP was then dialyzed extensively against several changes of distilled water and lyophilized. A sample containing 1.5 mg protein (Lowry procedure with BSA as a standard) contained 200 nmol glucosamine and no detectable galactosamine. Antisera Preparation. Adult sheep were immunized with a mixture containing 1 mg KSPG/CP in PBS and 1 ml of complete Freund's adjuvant or a comparable quantity of DSPG/CP. Two weeks later a similar quantity of antigen in 1 ml of incomplete Freund's adjuvant was injected. The sheep were bled after 2 weeks and approximately 50 ml of blood was allowed to clot at 37'C for 1 hr before transfer to a cold room at 4°C to allow the clot to retract. The sera were stored at -2O'C. Subsequent bleedings were done 4 and 8 weeks later. Antibody activity in sera was measured by ELISA with an ABC kit (Vector; Burlingame, CA). Sera from Bleedings 1, 2, and 3 were positive for aKSPG/CP (the antibody against the core protein of KSPG) in dilutions of 1:100,000, 1:10,000, and 1:10,000, respectively. The analogous titers for Bleedings 1 and 2 for aDSPG/CP (the antibody against the core protein of DSPG) were 1: l OOO and 1:lOOO. respectively; a third bleeding was not done.
aKSPGlCP in serum was purified by saturated ammonium sulfate precipitation. The recovered immunoglobulins were mixed with Sepharose-CNBr attached to KSPG/CP as recommended by Pharmacia (Uppsala, Sweden). Unbound proteins were removed with 0.15 M NaCl buffered with 0.05 M Tris, pH 7.4. Positive antibodies were eluted with 6 M urea and dialyzed against 0.1 M ammonium acetate, pH 7, followed by PBS. Aliquots of antibody were stored at -70°C. aDSPG/CP was only partially purified by saturated ammonium sulfate precipitation. Antibody Analysis. ELISA and Western blot analyses were used to determine antibody specificity. Partially purified rabbit corneal PGs were isolated as follows. Extracted corneal PGs (20) were fractionated by ethanol precipitation. The 55% and 70% ethanol fractions contained DSPG and KSPG, respectively. Each fraction was chromatographed on a Sepharose CL4B column (20). Glucosamine and galactosamine analyses (19) of KSPG and DSPG fractions indicated complete separation of PG types.
Sheep aKSPGlCP and aDSPG/CP (1:lOO) were tested against KSPG and DSPG with and without deglycosylation. KSPG was predigested with 0.25 Ulml endo-a-D-galactosidase (V-Labs; Covington, LA), followed by uifluoromethanesulfonic acid (40) to chemically deglycosylate the PG. DSPG samples were treated with 2.5 U/ml chondroitinase ABC in 0.2 M 'Ikis-HCl buffer, pH 8. Each digestion was conducted for 3 hr at 37°C. All solutions contained a combination of protease inhibitors including 10 mM disodium EDTA, 10 mM N-ethylmaleimide, 5 mM phenylmethyl-sulfonyl fluoride, and 0.36 mM pepstatin. Native and deglycosylated samples were run on 6-10% gradient mercaptoethanol SDS-PAGE and the proteins were treated with silver stain (32) or electroblotted for immunoanalysis to nitrocellulose sheets, which were incubated with purified sheep aKSPG/CP or aDSPG/CP and analyzed for antibodies with a Vector ABC kit. Antibodies were also tested against the GuHCI-extracted material that does not bind to the DEAE-Sepharose CL6B column before fractionation of corneal PGs with increasing NaCl concentrations. The "non-bound extracted fraction," which does not contain PGs, was dialyzed against water and tested for antibody binding by ELISA and Western blot analyses as described above. In addition, the antibodies were pre-incubated with the non-bound extracted fraction before immunohistochemistry to test for pre-absorption.
Immunofluorescence Microscopy. Adult rabbits, 1-week-old neonates, and two pregnant albino rabbits carrying 24-and 26-day-old fetuses were sacrificed with an overdose of pentobarbital. Fetuses were sacrificed by decapitation, Corneas were removed and frozen in OCT compound (Miles) at -20°C in preparation for cryostat sectioning.
Cryostat corneal cross-sections 6 pm thick were placed on gelatin-coated slides, briefly washed with PBS, pH 7.2, and incubated with sheep aKSPG/CP (adults) or aDSPGlCP (1-week-old neonates and 26-day-old fetuses) for 2 hr at room temperature (RT). After three washes in PBS for 10 min each at 4"C, the sections were incubated for 30 min at RT with F I X rabbit anti-sheep IgG antibody (Cappel; Malvern, PA) diluted 1:lOO. Non-immune sheep serum was substituted for primary antibody as controls. The sections, washed again with PBS. were covenlipped with 0.1% paraphenylenediamine in 90% glycerol. 10% PBS. pH 8, and viewed with a Zeiss epifluorescence microscope or a Zeiss Axiophoto microscope.
Immunocytochemistry. Transverse cryostat sections 10-12 pm thick of 26-day-old fetal rabbit comas were either mounted individually on gelatincoated microscope slides or pooled in groups of 30 sections. Sections were either fixed or not fixed before incubation with each antibody to determine the effect of chemical fmtion on immunogold localization. Tissue sections pre-fixed in 4% paraformaldehyde in PBS. pH 7.2. for 5 min were rinsed for 10 min in two changes of PBS at 4'C. Fixed and unfixed sections subsequently stained with polyclonal aKSPGICP and monoclonal aKS-GAG, an antibody specific to low-sulfated KS GAG (gift of Dr. Nirmala SundarRaj, Pittsburgh, PA) (42) . were digmed with 2.5 Ulml chondroitinax ABC (ICN ImmunoBiologicals; Costa Mesa. CA) in 0.05 M Tris HCI buffer. pH 8, for 3 hr at RT or incubated in buffer alone. After a wash in PBS. tissues were incubated overnight at 4°C in either polyclonal aKSPGICP, monoclonal aKSGAG (1:lO). polyclonal aDSPGlCP, monoclonal aA4S (1:5) (ICN ImmunoBiologicals) to detect chondroitin-4-sulfate GAG, or monoclonal aType VI collagen (1:500) (Chemicon; Temecula, CA or gift from Dr. Eva EngraII, La Jolla. CA). After removing excess antibody with PBS for 2 hr at 4°C. tissues trcated with sheep primary antibodia were incubated overnight at 4'C in 5-nm gold-conjugated rabbit anti-sheep IgG (13) (EX Laboratories; San Mateo, CA), followed by thret rinses in PBS. Tissua m t e d with mouse primary MAb were incubated in 5or 15-nm gold-conjugated rabbit or goat anti-mouse IgG (1:3) (E-Y Laboratories), followed by an cxtensive rinse in PBS.
Tissue samples were then processed for electron microscopy. The sections were rinsed bridly in 0.1 M cacodylate buffer, pH 7.4, fLvcd in a freshly prepared mixture of 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1 hr at 4'C. rinsed bridly in 0.1 M cacodylate buffer. and post-fixed in 1% buffered os04 for 1 hr at 4'C. The samples were dehydrated in a graded ethanol series and embedded in Medcast resin (Ted Pella; Rcdding, CA) or PolyIBed812 (Polyscicnccs; Warrington. PA) to obtain ultra-thin sections on grids. Grids were stained in 2% uranyl acetate in 50% ethanol for 15 min. followed by Reynolds' lead citrate for GO sec, and m i n e d with the Philips 410 transmission electron microscope.
Unfixed sections were used for double-labeling acperiments. After incubation with aDSPGICP or aKSPGICP and 5-nm gold-conjugated rabbit anti-sheep IgG. sections in a microfuge tube were washed in PBS for 2 hr at 4°C. Sections were then incubated with mouse aType VI collagen overnight at 4'C, followed by an extensive rinse in PBS. Localization of aType VI collagen was shown by incubation overnight at 4% with 15-nm colloidal gold-conjugated rabbit anti-mouse IgG (E-Y Laboratories). Tissue samples wcre then processed for electron microscopy as described above.
Control xctions for KSPGICP, DSPGICP, KSGAG, chondmitin-4-suffite GAG, and Type VI collagen immunocytochemistry were exposed to the same staining sequence, except that the primary antibody was replaced by PBS or non-immune sheep or mouse serum. In addition, controls for KSGAG included pre-incubation of sections for 3 hr at 37'C with 1. To test the possibility that the secondary antibodies crossreact betwcen sheep and mouse immunoglobulins, incubation of fetal cornea with sheep aKSPGICP or aDSPGICP was followed. after a rinse in PBS, by the addition of gold-conjugated anti-mouse IgG. Conversely, tissue incubated in mouse anti-human Type VI antibody was followed. after a rinse in PBS, by gold-conjugated rabbit anti-sheep IgG. 
Results

Antibody Analysis
Silver staining of a partially purified preparation of KSPG after SDS-PAGE appeared as a smear and prominent band at -60 KD (Figure 1. Lane 2) . Pre-treatment of the KSPG sample with endob-D-galactosidase led to the appearance of a new band at -40 KD (Figure 1, Lane 1) . Western blot analysis with sheep aKSPGlCP stained the KSPG preparation as a smear (Figure 1. Lane 3) . Endo-P-D-galactosidase-treated KSPG appeared as a dense band that migrated to the same position as the silver-stained core protein of KSPG (Figure 1, Lane 4) . aKSPGlCP failed to stain an immunoblot of our DSPG preparation pre-treated with chondroitinase ABC (Figure 2. Lane 5) . Faint staining in the blot is probably due to contamination with KSPG (see Materials and Methods).
SDS-PAGE of a partially purified preparation of adult corneal DSPGs appeared as a smear together with several bands of proteins at -300, 66, 55, and 40 KD (Figure 3 , Lane 1). Gels were overloaded to detect possible crossreactivity of the antibody with other proteins. Pre-digestion of the PG preparation with chondroitinase ABC gave rise to an additional band at 45 KD (Figure  3, Lane 2) . Western blot analyses showed that sheep aDSPG/CP antibodies recognize primarily the 45 KD enzyme-generated protein band (Figure 3, Lane 5) . A less densely stained smear and other minor bands were also seen in the preparation and in the standards, indicating minor crossreactivity.
SDS-PAGE of our KSPG preparation, plus or minus pretreatment with endo-p-D-galactosidase (Figure 4 , Lanes 1 and 2). was not recognized by the aDSPGlCP in the immunoblot (Figure  4, Lanes 3 and 4) . Anion-exchange chromatography (DEAE-Sepharose CL6B) of GuHC1-treated corneal extracts to extract and separate PGs from other proteins (20) yields an unbound fraction containing many proteins including collagens and glycoproteins, the non-bound extracted fraction. aKSPG and aDSPG/CP did not recognize the components of this unbound fraction in SDS-PAGE/Western blot analysis or ELISA (not shown).
Immunohistochemical analysis showed that binding of the aKSPGlCP and aDSPGlCP antibodies is limited to the extracellular matrix of corneal stroma in the adults and 26-day-old fetuses, respectively (Figure 5) . A similar staining pattern was seen in fetal, neonatal, and adult corneas for both antibodies (not shown). Preabsorption of antibodies with the non-bound extracted fraction did not change the immunohistochemical fluorescence compared with unabsorbed antibody (not shown).
In summary, antigen purification, Western blot analyses, and immunohistochemistry were used to test the specificity of aDSPGlCP and aKSPGICP. These results are consistent with the contention that these antibodies are specific for the core proteins of rabbit comeal DSPG (decorin and/or biglycan) and KSPG (lumican and/or fibromodulin), respectively.
Immunocytochemistry
Cryostat sections of the 24-day-old fetal corneal stroma treated with aKSPGlCP or aKSGAG for immunocytochemical analysis contained sparse bundles of collagen fibrils and abundant immunogold particles between these fibrils ( Figure 6 ). No label was associated with cellular structures (not shown). Many immunogold particles 
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were often grouped periodically, about 100 nm apart, over interfibrillar filaments. No marked difference was seen between tissues pre-fixed with paraformaldehyde and those unfixed (not shown). Pre-digestion of sections with chondroitinase ABC slightly improved the staining (not shown). Control samples incubated in normal serum in place of the primary antibodies lacked immunogold particles. Sclera from 24-day fetal eyes stained with aKSPG/CP showed a distribution of immunogold particles similar to that in the cor-neal stroma (Figure 7) . The antibody to the core protein of KSPG bound to fine interfibrillar filaments of the sclera. These filaments were also labeled with immunogold when the tissue was incubated with aType VI collagen. Unlike the cornea, sclera incubated with aKSGAG showed no positive labeling (not shown).
Fetal corneas stained with aDSPGlCP showed immunogold particles associated with a fine filamentous material between collagen fibrils (Figure 8 ). Unlike the periodic distribution of gold particles after incubation with aKSPGICP, staining after aDSPGICP was randomly arranged along the length of the interfibrillar filaments. A similar staining pattern was seen in 1-week-old neonate corneas.
Fetal corneas stained with aA4S. specific for chondroitin-4-sulfate GAG, showed a staining pattem similar to that of aDSPGlCP (Figure 9 ). Pre-digestion with chondroitinase ABC showed no difference in staining from non-digested tissue (compare Figures 9 and  8) . The immunogold particles were associated primarily with the interfibrillar filamentous material, with minimal staining of the collagen fibrils, and no apparent periodicity was noted in the distribution of immunogold particles. Differences in intensity of staining between Figure 8 and 9 are not significant. Double-labeling experiments with aDSPGlCP and aType VI collagen or aKSPGlCP and aType VI collagen showed that both antibodies to PGs bound primarily to Type VI collagen interfibrillar filaments (Figure 10) . In some instances double labeling was seen over collagen fibrils, indicating that Type VI filaments intertwine collagen fibrils. Tests to determine the possibility that the secondary antibodies crossreacted between sheep and mouse immunoglobulins were negative. romolecules in developing rabbit cornea. Purification of antigens to a single protein band on polyacrylamide gels, demonstration of antibody specificity to the protein core by Western blot analyses, antibody binding limited to extracellular matrix of corneal stroma, and failure of antibodies to bind to non-PG components of the GuHCI-extracted tissue strongly indicate that aKSPGlCP and aDSPG/CP are monospecific to the core proteins of KSPG
Discussion
We have developed and used antibodies to study the localization and association of corneal PGs with other extracellular matrix mac-(lumican and/or fibromodulin) and DSPG (decorin and/or biglycan), respectively. Using these and other well-characterized antibodies in immunocytochemistry, we have shown that both KSPG and DSPG in rabbit fetal cornea are associated with Type VI collagen filaments. However, the major caveats in interpreting immunocytochemical evidence are crossreactivity, masking, and movement of antigen.
KSPG
Although our observations of aKSPGICP binding indicate that KSPG is associated with Type VI collagen, Type VI collagen is replete with biantennary N-linked oligosaccharides in both the collagenous and non-collagenous domains (17, 41) , suggesting that the peptides linked with the oligosaccharides are immunologically similar to the GAG-lmkage region of the KSPG core protein. uKSPGlCP may therefore crossreact with Type VI collagen due to the presence of homologous epitopes. However, the paucity of homologous sequences of amino acids between lumican or fibromodulin and Type VI collagen does not support the presence of common epitopes (5, 13, 22) . Similarity in the ultrastructural localization of antibodies to KSPG/CP and low-sulfated KSPG GAG further supports the contention that KSPG is associated with Type VI collagen. Furthermore, aKSGAG binds to the globular region of Type VI collagen filaments in the cornea but fails to recognize an epitope in sclera (personal communication, Dr. Nirmala SundarRaj, Pittsburgh, PA), a tissue that also contains Type VI collagen. Assuming that Type VI collagen in sclera is immunologically similar to that in cornea, the difference in uKSGAG binding to these tissues suggests that the antibody does not recognize the oligosaccharides associated with Type VI collagen.
Although there is no evidence for low-sulfated GAGS in Type VI collagen, it is possible that polylactosamine components are present in some Type VI collagens (41) and may be recognized by aKSGAG. However, the chemically desulfated KSGAG polylactosamine is not recognized by aKSGAG (unpublished observations, Dr. Nirmala SundarRaj), and therefore it seems unlikely that a polylactosamine on Type VI collagen would be recognized by the antibody.
Because aKSPG/CP and aKSGAG are associated exclusively with Type VI collagen filaments and low-sulfated KSPG has been chemically identified in developing cornea (21), crossreactivity with other macromolecules in the tissue indicates co-localization of KSPG and crossreactive components with the globular domain of Type VI collagen. This immunocytochemical evidence has yet to be supported by in vitro binding assays to demonstrate that KSPG can bind to Type VI collagen.
DSPG
Similarity in immunobinding of our monospecific polyclonal antibody to the core protein and of the MAb to the 4-sulfated GAG of rabbit corneal DSPG to Type VI collagen filaments indicates that Type VI collagen is associated with DSPG in fetal cornea. Binding of aDSPGlCP after chondroitinase ABC treatment suggests that the core protein is involved in the association. This is supported by reports of solid binding assays showing a high affinity of Type VI collagen for decorin and of the association of hyaluronidaseor chondroitinase ABC-sensitive polyanions with fine filaments in adult bovine, mouse, and human infant cornea (4, 33, 44) .
Because decorin and biglycan are highly homologous, it is possible that our aDSPGlCP crossreacts with biglycan in corneal tissue. Biglycan, however, is restricted to the pericellular matrix components in a variety of fetal human tissues (3, 16) . Because we saw no immunogold staining associated with the cellular or pericellular components of the tissue, it is unlikely that aDSPGlCP is crossreacting with biglycan in fetal cornea. Nevertheless, we cannot discount crossreactivity at this time.
Preliminary observations in our laboratory and unpublished studies in another laboratory (Dr. Bjorn Olsen, Harvard Medical School, Boston, MA) indicate that Type XI1 collagen is present in mouse and rabbit cornea. Recent studies suggest that Type XI1 collagen, a fibril-associated collagen with interrupted triple helices (FACIT), contains a chondroitin sulfate chain similar to that in Type IX collagen (25) . Interestingly, our aDSPGlCP recognized a fusion protein from a rabbit corneal cDNA expression library coding for portions of Type XI1 collagen (unpublished observations). It is therefore possible that some of the label in the rabbit fetal cornea is associated with Type XI1 collagen. Nevertheless, the findings that aDSPGlCP is bound to only one kind of corneal structure, the Type VI collagen filaments, and that DSPG has been chemically identified in developing cornea (21) strongly suggest that DSPG in rabbit fetal cornea is associated with Type VI collagen. If Type XI1 collagen is also recognized by the antibody, the results suggest that this collagen is also associated with Type VI collagen filaments. Although crossreactivity does not seem to be a problem in the interpretation of our results, questions of masking and movement of the antigen must still be addressed.
Because our polyclonal and monoclonal antibodies together recognize several epitopes in each PG, it is unlikely that all of the epitopes of the PGs are masked. In addition, enzymatic digestion of the GAG of DSPG did not change the staining pattern for aDSPG/CP. As regards movement or wash-out of the antigen, removal of PGs from corneal tissues requires chaotropic substances such as GuHCI. In addition, pre-fixation of the corneal sections with paraformaldehyde did not change the staining pattern, suggesting that the PGs are not lost from the tissue.
Fetal us Adult Cornea
Our results showed no association of PGs with the collagen fibrils. This is contrary to observations in adult cornea where PGs, represented by the stained GAGS, were shown to associate specifically with periodic bands in the collagen fibrils (39) . Similarly stained GAGS in fetal cornea do not show the periodic pattern seen in adult corneas (7). Although we cannot explain this discrepancy, examination of the macromolecular differences between fetal and adult comeas may serve as hypotheses for future experiments.
PGs in fetal cornea differ from those in adult tissue in relative quantities of KSPG and DSPG, their charge densities, and the presence of hyaluronan and fibronectin in developing cornea (10,21). Sections of fetal cornea extracted extensively with NaCl removes PGS without disrupting collagen fibrils. Addition of purified adult KSPG to these tissue preparations leads to binding of the PGS to collagen fibrils in a periodic pattern similar to that in adult cornea (14). This suggests that the binding pattern is dependent on the source of PGs, i.e., adult vs fetal KSPG. Moreover, KSPG is present in several isoforms differing in core proteins as well as glycosylation (18,23). Immunohistochemically distinctive KSPG GAGS have been described in rabbit fetal corneas at different stages of development (42), supporting the contention that KSPGs in adult and developing corneas have different collagen binding properties.
Recent studies have shown that hyaluronan is structurally associated with Type VI collagen (24,30) . Although there is no evidence for a link protein in cornea, our observations can be partially explained by the possible association of PGs with hyaluronan in fetal cornea. On the other hand, treatment of crysotat sections of fetal cornea with chondroitinase ABC, known to digest hyaluronan as well as chondroitin sulfate (45), does not alter the binding of aDSPG/CP to the tissue.
Chick corneal collagen fibrils are composed of Types I and V collagen (29) . The proportion of Type V to Type I collagen in developing rabbit cornea changes from 6% in 23-day-old fetal cornea to 12% in a young adult (12). There is some evidence that some PGs interact with Type V collagen (26,43). If corneal PGs bind to collagen fibrils via Type V collagen, the association may be limited by availability of Type V collagen in the fibril. The lower concentration of Type V collagen in rabbit fetal cornea may be reflected by the paucity or lack of PGs bound to its collagen fibrils.
Although we do not have information on the quantity of Type VI collagen in fetal cornea, the marked morphological and molecular similarities between fetal and healing adult comea (8,9,11) suggest that the proportion of Type VI collagen in developing cornea may be similar to that in scar tissue. If so, the proportion of Type VI to Type I collagen would be approximately four times greater in fetal than in normal neonatal cornea. This marked difference in collagen ratios may favor the association of PGs with an abundant collagen, i.e., Type VI.
A prominent extracellular component in the developing rabbit cornea is fibronectin (10). Fibronectin gradually disappears in the developing stroma, remaining associated only with Descemet's membrane in the adult. Recent studies indicate that cardiac Type VI collagen is co-localized with fibronectin in the tissue (1) . Decorin, the major DSPG in corneal stroma, interacts with fibronectin via its core protein (38) . This suggests that corneal PGs are associated with Type VI collagen via fibronectin in fetal tissue.
Several potential macromolecular candidates are available to corneal PGs for intermolecular interactions within the tissue. This study provides an indication of some of these associations and possible interactions. Further studies of ultrastructural localization and interactions of these corneal macromolecules are crucial to an understanding of their physiological relevance.
